NextCure, Inc. (NXTC) Misses Q2 EPS by 17c

NextCure, Inc. (NASDAQ: NXTC) reported Q2 EPS of ($0.55), $0.17 worse than the analyst estimate of ($0.38).

For earnings history and earnings-related data on NextCure, Inc. (NXTC) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform
• Raymond James Upgrades Aecon Group (ARE:CN) (AEGXF) to Outperform